N-α-Boc-N-ω-tosyl-D-arginine

N-α-Boc-N-ω-tosyl-D-arginine is a protected D-arginine derivative featuring an N-terminal Boc carbamate and a side-chain ω-tosyl (tosylated guanidinium) group, preserving the stereogenic center at the α-carbon while masking the strongly basic functionalities. The molecule contains a carboxylic acid that can be converted into activated esters or amides, alongside a Boc-protected α-amine that supports controlled peptide coupling chemistry. The tosyl-protected guanidine is engineered to reduce side-chain reactivity during chain assembly while remaining a recognizable arginine motif for later deprotection and functional reconstitution. This combination of orthogonal protecting groups makes the compound a chiral, peptide-compatible amino acid intermediate suited for downstream synthetic elaboration and structure-defined peptide construction.

1. Peptide Synthesis

N-α-Boc-N-ω-tosyl-D-arginine is applied in peptide building workflows where orthogonal protection is required for stepwise N- and side-chain management. The Boc group enables standard amide bond formation at the α-position while remaining stable under many coupling conditions, and the ω-tosyl protection suppresses guanidinium side-chain participation during early stages. The D-configuration at the α-stereocenter supports stereochemically defined peptide analogs and can be used to introduce non-native chirality into peptide sequences for mechanistic studies. The resulting peptide products can be generated with arginine-like charge features restored after side-chain deprotection strategies, supporting iterative synthesis of protected arginine-containing fragments.

2. Chemical Biology

N-α-Boc-N-ω-tosyl-D-arginine is used in chemical biology research to construct charged amino acid motifs for probing biomolecular recognition and binding-site interactions. The arginine side-chain architecture, masked as a tosyl-protected guanidine, can be incorporated into peptides or peptidomimetics to control when cationic character is revealed during synthesis and subsequent conjugation. The Boc-protected α-amino functionality supports controlled assembly of peptide probes that can later be converted into active binding scaffolds through orthogonal deprotection and functional group transformations. The D-arginine stereochemistry can further be leveraged to assess stereochemical contributions to receptor-like interactions, enzyme recognition, and molecular recognition assays.

3. Bioconjugation Chemistry

N-α-Boc-N-ω-tosyl-D-arginine is suitable for bioconjugation intermediate preparation where arginine-derived handles are required for linker design and post-assembly functionalization. The protected guanidinium (ω-tosyl) reduces uncontrolled side reactions during conjugation reagent synthesis, while the carboxylic acid enables conversion into coupling-ready derivatives for attachment to biomolecule scaffolds. The Boc-protected α-amine can be maintained during linker construction and then unmasked in a controlled manner to support amide formation or further derivatization. Downstream conjugates may include arginine-containing peptide tags, affinity reagents, or charge-defined linkers used to study biomolecule interactions and to enable targeted labeling strategies.

4. Protected Amino Acid Chemistry

N-α-Boc-N-ω-tosyl-D-arginine is employed as a protected amino acid chemistry intermediate to enable orthogonally protected arginine building blocks for controlled deprotection sequencing. The Boc carbamate provides a predictable N-protection handle for peptide coupling and subsequent N-deprotection, while the ω-tosyl group functions as a side-chain protecting group compatible with multi-step synthesis. The combination supports selective transformation of the carboxyl group into activated intermediates for amide bond formation, while minimizing guanidine reactivity that can complicate purification and selectivity. This protection pattern supports manufacturing-relevant route design for fine chemical synthesis of protected arginine derivatives and for consistent preparation of stereodefined peptide fragments.

5. Peptidomimetics And SAR Studies

N-α-Boc-N-ω-tosyl-D-arginine is used in peptidomimetic construction and SAR studies where controlled incorporation of an arginine-like, side-chain-defined functionality is required. The tosyl-protected guanidine can be carried through scaffold assembly to maintain side-chain integrity, enabling synthesis of analog libraries with consistent stereochemistry and charge placement. The D-arginine configuration can be incorporated to tune conformational preferences and to evaluate stereochemical effects on binding or recognition without changing the protected synthetic handle set. The protected amino acid framework supports downstream generation of deprotected, cationic arginine analogs that can be integrated into structure-defined peptide mimics for systematic activity profiling and mechanistic comparison.

6. Pharmaceutical Manufacturing Intermediates

N-α-Boc-N-ω-tosyl-D-arginine is relevant to pharmaceutical manufacturing contexts as a stereodefined, orthogonally protected amino acid intermediate for producing protected peptide segments used in process-scale synthesis. The Boc-protected α-amino group and ω-tosyl-protected guanidine provide a protection scheme that can be integrated into peptide coupling trains while limiting side reactions from strongly basic functionalities. The carboxylic acid functionality supports formation of activated intermediates or coupling-ready derivatives under controlled process conditions, facilitating predictable incorporation into larger peptide structures. The resulting protected peptide building blocks can be advanced toward final deprotection and downstream functionalization steps, aligning with industrial chemical manufacturing needs for reproducible, stereochemically controlled intermediates.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction